)
Nevro (NVRO) investor relations material
Nevro Q4 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Fourth-quarter 2024 worldwide revenue was $105.5M, down 9.1% year-over-year; full-year 2024 revenue was $408.5M, down 3.9% from 2023.
Adjusted EBITDA for full-year 2024 improved to negative $13.6M from negative $17.7M in 2023, exceeding revised expectations.
Announced definitive agreement for acquisition by Globus Medical in an all-cash deal valued at ~$250M, expected to close in Q2 2025.
Launched HFX iQ SCS system with AdaptivAI in the US and select European countries following CE Mark certification.
Published new clinical data supporting efficacy of 10 kHz SCS therapy and SI Joint Fusion System.
Financial highlights
Q4 2024 U.S. revenue was $91.4M, down 9.9% year-over-year; international revenue was $14.1M, down 3.8%.
Gross margin for Q4 2024 was 62.5%, down from 70.1% in Q4 2023; full-year 2024 gross margin was 66.0%, down from 68.2%.
Q4 2024 net loss from operations was $51.4M (or $24.1M excluding one-time items); full-year net loss from operations was $126.2M.
Cash, cash equivalents, and short-term investments totaled $292.5M as of December 31, 2024, up $15.5M sequentially.
Adjusted EBITDA for Q4 2024 was negative $5.2M, compared to positive $8.4M in Q4 2023.
Outlook and guidance
No full-year 2025 guidance issued due to pending acquisition by Globus Medical; no earnings call or webcast held for Q4 and full-year 2024 results.
- Outperformed SCS market, expanded into SI joint fusion, and restructured for profitability.NVRO
2024 Truist Securities MedTech Conference3 Feb 2026 - Q2 revenue and margin declined; guidance cut and strategic review launched for future growth.NVRO
Q2 20242 Feb 2026 - Strategic review, AI product launches, and operational discipline drive near-term outlook.NVRO
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Revenue fell 6.7% but profitability and guidance improved amid new AI product launches.NVRO
Q3 202415 Jan 2026 - Globus Medical acquires Nevro to expand into pain management, targeting late Q2 2025 close.NVRO
M&A Announcement6 Jun 2025
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)